Amarillo Public Health now scheduling new antibody infusion treatments for COVID patients

Published: Jan. 14, 2022 at 11:19 AM CST
Email This Link
Share on Pinterest
Share on LinkedIn

AMARILLO, Texas (KFDA) - The Amarillo Public Health Department has received a shipment of the monoclonal antibody infusion medication, Sotrovimab.

APHD is now scheduling patients for treatment, beginning with those already on the referral list.

The department said they will move on to new patients as monoclonal antibody supplies last.

Copyright 2022 KFDA. All rights reserved.